By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Modern WisdomEx-Pharma Rep: It's Way More Corrupt Than You Think - Brigham Buhler
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Insider Exposes How US Healthcare Profits From Keeping People Sick
- Former pharma and device rep Brigham Buhler explains how American healthcare incentives are structured to monetize chronic disease rather than prevent it, making it the leading cause of personal bankruptcy. He details how insurance companies and pharmacy benefit managers (PBMs) quietly dominate the system, earning far more than Big Pharma while pushing patients toward more drugs and delayed, restricted care. The conversation covers corporate capture of regulators like the FDA and NIH, suppression of cheaper or safer alternatives (compounding pharmacies, peptides, psychedelics, stem cells), and how perverse incentives contributed to crises like opioids. Buhler argues that true reform requires cash-pay, preventive, metabolically focused care supported by AI-driven, continuous monitoring and strong conflict-of-interest rules for regulators.
IDEAS WORTH REMEMBERING
5 ideasUS health incentives are designed to profit from chronic disease, not prevent it.
Insurers, PBMs, hospitals, and even oncologists are financially rewarded when patients need more drugs, procedures, and repeat surgeries; there is little economic upside in actually resolving or preventing chronic illness.
Insurance companies and PBMs quietly make more from drugs than Big Pharma.
The top five insurers earn roughly 4x the revenue of the top five drug makers, largely by owning PBMs that negotiate upward drug prices via rebates and then pass the inflated costs to employers, incentivizing more prescriptions.
Regulatory agencies are deeply corporately captured through revolving doors and royalties.
FDA leaders routinely leave for high-paid roles at the companies they once regulated, NIH-developed drugs funded by taxpayers are patented and monetized by pharma, and HHS helped entrench the PBM/insurance structure—undermining public trust and safety.
Many effective or cheaper therapies are attacked to protect entrenched revenue streams.
Compounding pharmacies, peptides, ketamine pain creams, ibogaine, psilocybin, and stem cells are often restricted or smeared—not primarily for safety, Buhler argues, but because they threaten patented products and high-margin chronic prescriptions.
Both US and UK systems largely fail at preventive and metabolic health.
In the US, six–ten minute appointments and insurance rules block comprehensive labs and proactive screening; in the UK, overburdened GPs focus on the sickest cases, leaving almost no structural support for people who want to move from ‘okay’ to optimal health.
WORDS WORTH SAVING
5 quotesOur healthcare system is not broken. It’s rigged, and we’re the ones footing the bill.
— Brigham Buhler
If you show me the incentives, I’ll show you the outcomes.
— Brigham Buhler
We spend more on healthcare than any other nation, but we’re one of the fattest, sickest, and most chronically ill societies in the history of the world.
— Brigham Buhler
The answer’s not at the bottom of a pill bottle, man. It never has been. It never will be.
— Brigham Buhler
This is not Republican versus Democrat. It’s humanity versus corporate capture.
— Brigham Buhler
High quality AI-generated summary created from speaker-labeled transcript.
